Reata Pharmaceuticals
Why Robinhood?
You can watch RETA and buy or sell other stocks, ETFs, and their options commission-free!About RETA
Reata Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, developing, and commercializing pharmaceutical products. Its product candidates are bardoxolone methyl and omaveloxolone, which activate the transcription factor Nrf2 to restore mitochondrial function, reduce oxidative stress, and resolve inflammation.
RETA Key Statistics
Stock Snapshot
As of today, Reata Pharmaceuticals(RETA) shares are valued at $172.36. The company's market cap stands at 6.57B, with a P/E ratio of -57.67.
Reata Pharmaceuticals(RETA) stock opened on 2026-05-08 at —. The price climbed to — and dipped to —.
Reata Pharmaceuticals(RETA) shares are trading with a volume of 0, against a daily average of 610.38K.
In the last year, Reata Pharmaceuticals(RETA) shares hit a 52-week high of $172.46 and a 52-week low of $21.83.
In the last year, Reata Pharmaceuticals(RETA) shares hit a 52-week high of $172.46 and a 52-week low of $21.83.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.